Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

A lawsuit filed by the Federal Trade Commission alleges Evoke Wellness LLC and its management services company used deceptive ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Every Cure, a leading nonprofit dedicated to identifying and validating new uses for existing drugs, today announced an expanded collaboration with Google Cloud to advance AI-driven drug repurposing.

Firefighters uncovered a hidden drug lab while battling a four-alarm blaze in a Bronx apartment building, according to an ...

Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in ...

Every Cure researchers use Google Cloud's infrastructure to stay at the cutting edge of drug repurposing, an approach that can bypass the prolonged timelines and high costs associated with ...

Servier is extending its pact with Google Cloud as the French biopharma points to 60 examples of how generative artificial intelligence could improve its drug development processes. The two ...